Results 201 to 210 of about 26,689 (268)

Clinical considerations on the use of evinacumab for the treatment of homozygous familial hypercholesterolemia. [PDF]

Am J Prev Cardiol
Bajaj A, McGuire M, Shugg S, Godin R, Underberg JA.   +4 more
europepmc   +1 more source

Comparative analysis of low- and high-dose apheresis platelets in platelet-refractory patients with hematologic malignancies. [PDF]

Hematol Transfus Cell Ther
Rajendran S, Sharma RR, Hans R, Malhotra P, Lamba DS.   +4 more
europepmc   +1 more source

Lesion-level PET/CT analysis to identify predictors of progression after BCMA CAR T-cell therapy in multiple myeloma. [PDF]

Blood Cancer J
Dreyfuss AD, Yahalom J, Rajeeve S, Lesokhin AM, Shah GL, Landau HJ, Merz M, Scordo M, Derkach A, Nemirovsky D, Hubbeling H, Cederquist G, Moore ZR, Giralt SA, Mailankody S, Usmani SZ, Imber BS, Hashmi H.   +17 more
europepmc   +1 more source

Assessment of the efficacy of large volume delayed sampling primary culture and pathogen reduction in preventing septic reactions from platelet transfusions. [PDF]

Transfusion
Jacobs MR.
europepmc   +1 more source

Lipoprotein(a): a potential target for the reduction of residual cardiovascular risk in patients with chronic kidney disease. [PDF]

Front Nephrol
Sechi LA, Bulfone L, Vacca A, Comand J, Marcante S, Brosolo G, Pagano C, Catena C.   +7 more
europepmc   +1 more source

Public availability of trial-design and clinical-context information in contemporary lipoprotein(a)-targeted cardiovascular trials: A cross-sectional meta-research study. [PDF]

Am Heart J Plus
Tan S, Gu J, Yow D, Zheng L.
europepmc   +1 more source

Successful autologous T cell apheresis in pediatric patients with hematologic malignancies, solid tumors, and brain tumors. [PDF]

Cytotherapy
Murphy D, Bi Y, Patel A, Li Y, Zheng Y, Poston L, Akel S, Kilpatrick C, Lockey T, Zhou S, Bertrand KC, DeRenzo C, Naik S, Sharma A, Talleur AC, Velasquez MP, Triplett BM, Gottschalk S, Selukar S, Epperly R.   +19 more
europepmc   +1 more source

Correction to "Real-World Safety Data From the World Apheresis Association Registry for the Spectra Optia Apheresis System". [PDF]

J Clin Apher
europepmc   +1 more source

The ABC of apheresis

Acta Clinica Belgica, 2014
Apheresis is a collective term for several activities in which a desirable specific blood component is separated and collected or a harmful component is removed. During the last decades the application of apheresis has expanded to a broad spectrum of diseases due to various studies on the clinical efficacy of this therapy as well as the innovation of ...
D, Dierickx, E, Macken
openaire   +3 more sources